Lipiodol lymphangiography as a treatment for refractory postoperative chylothorax: a case report

Submitted: November 11, 2020
Accepted: April 28, 2021
Published: June 7, 2021
Abstract Views: 923
PDF: 434
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Postoperative chylothorax is the most frequent cause of traumatic thoracic chyle leakage. Conservative treatment is primarily used to treat low flow rate chylothoraces and should be initiated as soon as the diagnosis has been made. In case of high flow rate chylothorax or failure of initial treatment, surgery and radiological treatment are indicated. Despite this fact, there is a lack of consensus regarding the best therapeutic option to choose. In the case reported herein, a postoperative chylothorax with a low flow chyle leakage which didn’t respond to conservative treatment is demonstrated. We used lipiodol lymphangiography to determine the site of chyle leakage and to successfully treat our patient. Risk factors for non-response to conservative treatment are also discussed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Cholet C, Delalandre C, Monnier-Cholley L et al. Nontraumatic chylothorax: Nonenhanced MR lymphography. Radiographics 2020;40:1554-73. DOI: https://doi.org/10.1148/rg.2020200044
Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007;32:362-9. DOI: https://doi.org/10.1016/j.ejcts.2007.04.024
Bryant AS, Minnich DJ, Wei B, Cerfolio RJ. The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection. Ann Thorac Surg. 2014;98:232-7. DOI: https://doi.org/10.1016/j.athoracsur.2014.03.003
Schild HH, Strassburg CP, Welz A, Kalff J. Treatment options in patients with chylothorax. Dtsch Arztebl Int 2013;110:819. DOI: https://doi.org/10.3238/arztebl.2013.0819
Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 2016;49:18–24. DOI: https://doi.org/10.1093/ejcts/ezv041
Kranzfelder M, Gertler R, Hapfelmeier A, et al. Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis. Surg Endosc 2013;27:3530-8. DOI: https://doi.org/10.1007/s00464-013-2991-7
Ohkura Y, Ueno M, Shindoh J et al. Risk factors for postoperative chylothorax after radical subtotal esophagectomy. Ann Surg Oncol 2018;25:2739-2746. DOI: https://doi.org/10.1245/s10434-018-6640-1
Suetsugu T, Tanaka Y, Banno S, et al. Intranodal lymphangiography for chyle leakage after esophagectomy: A case report. Mol Clin Oncol 2020;12:343-349. DOI: https://doi.org/10.3892/mco.2020.1990
Lee KH, Jung JS, Cho SB, et al. Thoracic duct embolization with lipiodol for chylothorax due to thoracic endovascular aortic repair with debranching procedure. Korean J Thorac Cardiovasc Surg 2015;48:74-7. DOI: https://doi.org/10.5090/kjtcs.2015.48.1.74
Skandalakis JE, Skandalakis LJ, Skandalakis PN. Anatomy of the lymphatics. Surg Oncol Clin N Am 2007;16:1–16. DOI: https://doi.org/10.1016/j.soc.2006.10.006

How to Cite

Lamine, Nesrine, Apostolos C. Agrafiotis, and Ines Lardinois. 2021. “Lipiodol Lymphangiography As a Treatment for Refractory Postoperative Chylothorax: A Case Report”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1676.